BCOR/L1-mutated MDS was characterized by severe thrombocytopenia, high blast counts, a shorter OS (median, 2.2 years), and a 24% 2-year incidence of AML transformation [17]. This evidence concerns the gene BCORL1 and myelodysplastic syndrome.